Live feed
Filing
SC 13G
SC 13G0001535610-20-000069·Phio Pharmaceuticals Corp.
Schedule 13G ownership disclosure
Phio Pharmaceuticals Corp.
Security class unavailable · CUSIP: 71880W303
Event date: 2020-02-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 185,705
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-20-000069
- Form type
- SC 13G
- Filer
- Phio Pharmaceuticals Corp.
- CIK
- CIK 1533040
- Filed
- Feb 11, 2020
- Reporting period
- Feb 11, 2020
- Description
- Schedule 13G beneficial ownership